Related Experiment Video
Updated: Feb 6, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Differential MicroRNA Expression between EGFR T790M and L858R Mutated Lung Cancer
Ji Yeon Kim1, Woo Jeong Lee2, Ha Young Park3
1Department of Pathology, Inje University Haeundae Paik Hospital, Busan, Korea.
Background:
MicroRNAs (miRNAs) are short, non-coding RNAs that mediate post-transcriptional gene regulation. They are commonly deregulated in human malignancies, including non-small cell lung cancer (NSCLC). The aim of this study is to investigate miRNA expression in T790M-mutated NSCLC resistant to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
Methods:
Six cases of resected NSCLC harboring the T790M mutation were examined. We performed miRNA time polymerase chain reaction (PCR) array profiling using EGFR T790M-mutated NSCLC and L858R-mutated NSCLC. Once identified, miRNAs that were differentially expressed between the two groups were validated by quantitative real-time polymerase chain reaction (qRT-PCR).
Results:
miRNA PCR array profiling revealed three up-regulated miRNAs whose expression levels were altered 4.0-fold or more in the EGFR T790M mutation group than in the L858R group: miR-1 (fold change, 4.384), miR-196a (fold change, 4.138), and miR-124 (fold change, 4.132). The three differentially expressed miRNAs were validated by qRT-PCR, and they were found to be overexpressed in the T790M group relative to L858R group. In particular, expression levels of miR-1 and miR-124 were significantly higher in the T790M group (p-value of miR-1 = .004, miR-124 = .007, miR-196a = .096).
Conclusions:
MiR-1, miR-124, and miR-196a are overexpressed in EGFR T790M mutated NSCLC.
Insights
MicroRNAs (miRNAs) are deregulated in non-small cell lung cancer (NSCLC). This study found miR-1, miR-124, and miR-196a are overexpressed in EGFR T790M-mutated NSCLC resistant to tyrosine kinase inhibitors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression.
- Aberrant miRNA expression is implicated in various cancers, including non-small cell lung cancer (NSCLC).
- Acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is a significant clinical challenge in NSCLC, often associated with the T790M mutation.
Purpose of the Study:
- To investigate the differential expression of miRNAs in NSCLC with the EGFR T790M mutation.
- To identify specific miRNAs associated with resistance to EGFR TKIs in NSCLC.
Main Methods:
- Analysis of miRNA expression profiles in six cases of resected NSCLC harboring the T790M mutation.
- Comparison of miRNA expression using miRNA polymerase chain reaction (PCR) array profiling between EGFR T790M-mutated and L858R-mutated NSCLC.
- Validation of differentially expressed miRNAs using quantitative real-time PCR (qRT-PCR).
Main Results:
- miRNA PCR array profiling identified three miRNAs (miR-1, miR-196a, miR-124) with significantly altered expression (≥4.0-fold change) in the T790M group compared to the L858R group.
- Validation by qRT-PCR confirmed the overexpression of miR-1, miR-196a, and miR-124 in the T790M-mutated NSCLC.
- miR-1 and miR-124 showed particularly significant overexpression in the T790M group (p < 0.01).
Conclusions:
- MiR-1, miR-124, and miR-196a are significantly overexpressed in EGFR T790M-mutated NSCLC.
- These miRNAs may play a role in the development of resistance to EGFR TKIs in NSCLC.
- Further investigation into the functional roles of these miRNAs could offer potential therapeutic targets.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cancers Originate from Somatic Mutations in a Single Cell
Viral Mutations

